Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Peacefulwendy. ...the next few months are gonna be exciting. ..we have 2 major events taking place with CIB....EMA approval and Von Hoff preclinical results....it should get us moving...i am not even thinking about selling near term as i believe this stock is headed into dollar land and beyond ...
Not if...but when EMA approves CIB for orphan status...this news will be shared with FDA.. EMA and FDA share info...http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm386372.htm
JJ...seems we have spent time doing our DD...one thing i can say is that the people involved with cell in box have taken a careful approach to moving it to the next level....nvlx has assembled the very best to move it forward....and imagine that von hoff approached nvlx to perform a preclinical using cell in box....that about sez it all. Apparently, cell in box is known among medical community.
If we become gold standard for pancreatic cancer...And then have successful diabetes trials...pps will go to $20 to $30/share....there is little doubt about it. Diabetes treatment is huge....i feel we should start diabetes trials within a year....fast track for pancreatic cancer will establish nvlx....institutions will begin pouring money into this stock....glta longs!
Fuse is lit....kaboom time coming!
Bull....a very sensible post.
There is no deception here....it's just a young bio crossing Ts and dotting I s....i am not worried at all...seems there is a agenda to discredit this young company with great promise. I am sure there are some out there that don't want this company to succeed for obvious reasons...but if this technology works it will succeed...patients will demand it. Nothing will be able to stop this technology from getting out to the public...fda will...and i repeat...will fast track this technology...if you are a novice investor and can't take the hits this stock is going through...then my advice is sell. A company that has attracted the likes of Crabtree and von hoff has my full attention. Good luck to all longs.
Peacefulwendy. ...i dont post here very often but I do appreciate what you and a few other do here...keep the positive info flowing....traders...shorts ...will keep doing what they do....have faith in von hoff and crabtree... these guys are the keys to moving cell in box forward...von hoff has done it before with gemzar and abraxane to name a few...crabtree has done it with taxol...what a team we have....big brothers salmons...gunzburg and lohr are there to guarantee success...this is gonna be a hit....but i believe buyout will happen.
Peacefulwendy....you mean we know what we own!
Look at what the technology of this .28 stock has accomplished....European orphan drug status....phase 2b that knock the socks off of gemzar and abraxane....attracted the likes of Crabtree...von hoff and lohr....and those on the mj side as well....this will rocket....soon!
I would say that most people who dd this technology are investing in it.. maybe a little at a time or maybe alot...you can bet there are many who have it on their watch list...there is no question that if nvlx replicates their previous phase 2b results...this company will be bought out...there is no question in my mind about this...big pharma just cannot let this technology run rampant in the treatment world....whoever buys it will reap huge $$$$ and investors in nvlx will be very happy people...
Show me a company where pps is .28 and heading to a phase 2b and starting preclinicals with dr von hoff at the helm....you can't!....huge upside here....risk takers retire happy....this is not even considered risk taking in my book....it rec'd European orphan drug status...phase 2b confirmed previous studies results....this is headed for fast track and von hoff will make it even easier to obtain it....i feel since he has recent ties with celgene regarding abraxane...celgene will gobble us up...don't think celg doesn't have a cup on the wall of von Hoff's lab...good luck to all longs....our time is fast approaching.
Hi peacefulwendy... keep up the good fight....you and others.
A home run? More like a world series winning walk off grand slam...just think about who is involved with cell in box....von hoff (does he need an introduction? )...crabtree (brought taxol thru fda when he was bristol myers)...lohr (mastermind of phase 1 and 2 cell in box)...and we sit at .27? Wait till the world finds out after pain mgmt and/or phase 2b results come about...both lilly and Celg will sheet in pants...
Reverse split? Well let me imagine who started that rumor...not likely to happen...what would be the purpose? We will be getting earth shattering news...it's right around the corner...preclinical studies for pain mgmt is just about under way...when von hoff speaks investors listen and they will come running....phase 2b will lead to fast track....mj grant probably in the works...and diabetes could get under way...these events will lead to enormous pps rise...we could then apply to other exchanges if that's what you are looking for...that will then lead to institutional investors wanting in...don't let nay sayers plant seeds...be patient and be rewarded!
Here is something you can share with family...friends...or anyone. Nice concise easy to understand summary of what nvlx is all about... http://www.medicaljane.com/2014/06/10/nuvilex-medical-marijuana-sciences-furthering-cancer-research/#
Would like to hear how this presentation went...and take note that Chardan Capital is a sponsor... http://www.ldmicro.com/companies/nvlx/
Otsy...i believe we will see pps appreciation towards .50 to $1 sometime this year. Tumor shrinkage, from what I understand, should occur within 4 to 6 weeks of treatment...i am not convinced pr guy is well informed as i have dealt with marlin in the past and he knew nothing. ..i will only believe a pr release from nvlx regarding trial dates and such. Competition is tough in this arena...nvlx likes to hold info close to vest.
Excellent point about the pain reduction timetable...why not study this while we await phase 2b results and then head toward fast track review.
Hi Peacefulwendy...not sure if it's celg but we are at a second phase 2b...we have some of most respected scientists/Dr's in our camp....and our first phase 2b was a success. Cell in box has already received European orphan drug status...we are way ahead of OncoMed as they are at phase 1....their is no doubt in my mind that someone is talking with us...i just believe that whoever it is wants to see tumor shrinkage and how fast it takes place...then news may come about...jmho
Phu anh pham...that's what it's all about...do your dd...then make an investment decision...gl
Great...they are paying 3.3bil for co marketing rights for OncoMed therapies and only one has gone thru phase 1? Wow....Our cell in box is going thru a 2nd phase 2b and cell in box has successful preclinical studies for diabetes...plus cell in box is clearly headed for fda review for fast track....so how much is cell in box worth? I think more than 3.3bil.....
Are we being prepped for an offer? Luv it!
Oh jeez...figgins (bbbs)...leave these fine people alone. Haven't you had enough fun for the day at you know where...
Thanks Peacefulwendy...so far from what I have seen...nvlx has been meticulously building this company and adding the right people to guide it....i expect sometime between now and end if year we will hear something whether leaked or reported that our tech in phase 2b was successful in shrinking pancreatic cancer tumors...i think i read somewhere that this occurs between 4 to 6 weeks? Anyone?
Remember nvlx (subsidiary MMS) is not your typical mj stock...The goal is to take medical benefits of mj and use it against diseases/illnesses/disorders...Most other mj stocks are involved in the retail side of the business....
Just one note....we already know that von hoff was behind getting gemzar and abraxane thru fda...but also be reminded that Dr Lohr was involved in earlier CTs on cell in box...so he knows what we have and the results previously produced...he was there...
Been here a long time...From my view...this company since becoming involved with sg austria has taken its time moving along but has made exceptional decisions on who to bring on board and I don't believe they will flop on any of their studies...Some of the best are now involved with this company....it is quite normal for this company to be doing things behind the scenes...There are competitors out there and nvlx is holding more info than we know close to their vests....long and strong for quite a while....unnerved and unshaken...
Interesting read as we are now researching with U of N Colorado.... http://www.dddmag.com/news/2013/12/compounds-cannabis-could-limit-stroke-damage?cmpid=related_content
Setay....like I said before....i agree completely with your earlier post
Peacefulwendy...no pr was issued on our last phase 2b in 2011...pr issued only after results were known....i hope we get a recruitment pr...CNS should be getting prep work done for phase 2b...definite exciting times ahead!
News out...research agreement signed....read up.http://www.otcmarkets.com/stock/NVLX/news
In case anyone wants to know...The main difference, from what I understand, between their cell encapsulations and ours is simple....Our cells do not cause an immune response. Therefore, it can stay in the body longer. Do your DD.
Yeah...and it now looks like the y board monitors are in bed with shorts....they are deleting many longs good posts....they leave the short garbage alone...
Thanks carson...Hey some of those guys on y board are my friends...yeah we get carried away but with fda fast tracking we could get a break...i am no expert but if phase 2b shows tumor shrinkage faster than other treatments. ..well you never know...
Some of you have got this all wrong....this is not a get rich quick scheme...it's an investment. ..and for many, like myself, its a long term investment. ..so do your dd...have confidence in your dd or get out...names like von hoff and Lohr are not associated with many stocks and we are fortunate to have them here......screw the prs...they are not for us longtimers/believers. ..they are meant to attract new investors...and it takes $$$$$ to attract new investors...nvlx mgmt is seasoned and know what they are doing...My opinion is...this will be bought out...names like von hoff and Lohr will make it that much easier to attract a suitor....don't think for a moment that celg is not paying attention. ..Our technology has the potential to affect their bottom line.
A lot of interesting discussion going on here...since Dr von hoff just finished bringing abraxane thru fda approval for celgene does anyone think celgene is not still in communication with him? Connections are probably still in tact...lots of prs from nuvilex must have peeked interest from celgene...they are not blind and are always paying attention to new technology...was Dr von hoff introduced to nvlx by way of celgene? Is nuvilex already in talks with celgene? Is CNS really just doing a phase 2b as a requirement from celgene before a buyout offer? And is von hoff in place waiting his turn for the phase 3? Are these recent moves being orchestrated by celgene?...Cell in box will be a big $$$$ producer....i cannot believe big pharma has not taken notice of cell in box previous clinical trial results....i too smell some kind of merger/acquisition in the air....and if this could be the new gold standard and not just another option...buyout price could be big! In addition...seems as if pps is being held at this level...is there pps manipulation going on here...would it not benefit a buyer to keep pps as low as possible?